Jessica Gordon
Hospital for Special Surgery(US)Cornell University(US)Valley Medical Center(US)Max Planck Institute of Psychiatry(DE)Weill Cornell Medicine(US)
Publications by Year
Research Areas
Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Dermatologic Treatments and Research, Inflammatory Myopathies and Dermatomyositis, Mast cells and histamine
Most-Cited Works
- → Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients(2015)337 cited
- → Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8(2018)234 cited
- → Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial(2019)220 cited
- → Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial(2011)174 cited
- → Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile(2019)173 cited
- → Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry